Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solventum (SOLV) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Solventum (SOLV) over the last 3 years, with Q3 2025 value amounting to $1.3 billion.

  • Solventum's Income from Continuing Operations rose 93770.49% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 11152.78%. This contributed to the annual value of $478.0 million for FY2024, which is 6448.74% down from last year.
  • Latest data reveals that Solventum reported Income from Continuing Operations of $1.3 billion as of Q3 2025, which was up 93770.49% from $90.0 million recorded in Q2 2025.
  • Solventum's 5-year Income from Continuing Operations high stood at $1.3 billion for Q3 2025, and its period low was $30.0 million during Q4 2024.
  • In the last 3 years, Solventum's Income from Continuing Operations had a median value of $237.0 million in 2024 and averaged $301.5 million.
  • As far as peak fluctuations go, Solventum's Income from Continuing Operations tumbled by 8897.06% in 2024, and later surged by 93770.49% in 2025.
  • Solventum's Income from Continuing Operations (Quarter) stood at $272.0 million in 2023, then tumbled by 88.97% to $30.0 million in 2024, then skyrocketed by 4120.0% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $90.0 million for Q2 2025, and $137.0 million during Q1 2025.